Full text loading...
View Affiliations Hide Affiliations
FN1Financial support: This publication was made possible through core services and support from the Penn Center for AIDS Research (CFAR), an NIH-funded program (P30 AI 045008) and benefitted from funding from the Children's Hospital of Philadelphia Research Institute (to Andrew P. Steenhoff).
FN2Authors' addresses: Michael J. A. Reid, Department of Medicine, University of California San Francisco Medical Center, San Francisco, CA, E-mail: firstname.lastname@example.org. Rebecca S. B. Fischer, Department of Epidemiology, Baylor College of Medicine, Houston, TX, E-mail: email@example.com. Naledi Mannathoko, School of Medical Sciences, University of Botswana, Gaborone, Botswana, E-mail: firstname.lastname@example.org. Charles Muthoga, Laboratory Sciences, Botswana UPenn Partnership, Gaborone, Botswana, E-mail: email@example.com. Erin McHugh, Department of Medicine, University of Texas, Houston, TX, E-mail: firstname.lastname@example.org. Heather Essigmann and Eric L. Brown, Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX, E-mails: email@example.com and firstname.lastname@example.org. Andrew P. Steenhoff, Children's Hospital of Philadelphia, Department of Pediatrics, Philadelphia, PA, E-mail: email@example.com.
- The American Society of Tropical Medicine and Hygiene
- Source: The American Journal of Tropical Medicine and Hygiene, Volume 96, Issue 4, Apr 2017, p. 795 - 801
Prevalence of Staphylococcus aureus Nasal Carriage in Human Immunodeficiency Virus–Infected and Uninfected Children in Botswana: Prevalence and Risk Factors
Staphylococcus aureus is an important cause of morbidity and mortality in children in sub-Saharan Africa (SSA). A major risk factor for staphylococcal infection is S. aureus colonization of the anterior nares. We sought to define risk factors for S. aureus carriage and characterize antimicrobial resistance patterns in children in Botswana. A cross-sectional study was conducted at two clinical sites in southern Botswana. Patients under 18 years of age underwent two nasal swabs and brief interviews, 4 weeks apart. Standard microbiological techniques were used. For persistent carriers, S. aureus was isolated from swabs at both time points, and for intermittent carriers, S. aureus was isolated from only one swab. Poisson regression with robust variance estimator was used to compare prevalence of carriage and the resistance phenotypes. Among 56 enrollees, prevalence of S. aureus colonization was 55% (N = 31), of whom 42% (N = 13) were persistent carriers. Of human immunodeficiency virus–infected children, 64% (N = 9) were carriers. Risk factors for nasal carriage included a history of tuberculosis (prevalence ratio [PR] = 1.60; 95% confidence interval [CI] = 1.02, 2.51; P = 0.040) and closer proximity to health care (PR = 0.89; 95% CI = 0.80, 0.99; P = 0.048). Prior pneumonia was more common among persistent rather than intermittent carriers (PR = 2.64; 95% CI = 1.64, 4.23; P < 0.001). Methicillin-resistant S. aureus (MRSA) prevalence was 13%. Of isolates tested, 16% were resistant to three or more drugs (N = 7/44). In summary, children in southern Botswana are frequently colonized with S. aureus. Antibiotic resistance, especially MRSA, is also widespread. Antibiotic recommendations for treatment of staphylococcal infections in SSA should take cognizance of these resistance patterns.